ArticleJournal for immunotherapy of cancer2025

Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors.

Anthony K Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.